文献速递垂体与肾上腺疾病

COVID-19相关双侧肾上腺梗死致原发性肾上腺皮质功能不全:一例病例报告

Primary adrenal insufficiency due to bilateral adrenal infarction in COVID-19: a case report.
PubMed 文献 · J Clin Endocrinol Metab · 2021-07-29

本文报告一例46岁女性在COVID-19感染后出现腹痛、低血压、皮肤色素沉着,检查示低钠血症、皮质醇<1.0 ug/dL、ACTH 807 pg/mL、醛固酮<3 ng/dL,CT示双侧肾上腺增大伴无实质强化及轻微周边包膜强化,符合双侧肾上腺梗死。患者有自身免疫性肝炎及抗磷脂抗体阳性,但无既往血栓事件。文献回顾共纳入9篇关于COVID-19中新发肾上腺功能不全和/或肾上腺出血/梗死的病例报告,结论支持COVID-19触发的抗磷脂综合征与双侧肾上腺梗死相关,建议抗磷脂抗体阳性者在COVID-19期间密切监测急性肾上腺功能不全症状。

要点

  • COVID-19患者出现低血压、低钠血症、色素沉着需警惕急性原发性肾上腺功能不全。
  • 双侧肾上腺梗死可发生于抗磷脂抗体阳性者,COVID-19可能触发抗磷脂综合征。
  • 抗磷脂抗体阳性者在COVID-19期间应密切监测急性肾上腺功能不全的症状和体征。

核心结论

  • 本病例支持COVID-19触发的抗磷脂综合征与双侧肾上腺梗死之间的关联。

研究设计与样本

  • 病例报告:一例46岁女性COVID-19感染后出现肾上腺功能不全。
  • 文献回顾:检索115篇文章,纳入9篇关于COVID-19中新发肾上腺功能不全和/或肾上腺出血/梗死的病例报告。

主要发现

  • 患者血清皮质醇<1.0 ug/dL,ACTH 807 pg/mL,醛固酮<3 ng/dL,CT示双侧肾上腺增大伴无实质强化及轻微周边包膜强化,符合双侧肾上腺梗死。
  • 文献中5例经激素诊断肾上腺功能不全,但仅3例测量ACTH(1例高、2例正常/低)。
  • 文献中5篇报告双侧肾上腺非出血性或出血性梗死(2例有肾上腺功能不全、2例皮质醇正常、1例无数据)。
  • 文献中唯一一例COVID-19后明确诊断的新发急性原发性肾上腺功能不全患者既往已诊断抗磷脂综合征。

关键数值与推荐

  • 患者皮质醇<1.0 ug/dL、ACTH 807 pg/mL、醛固酮<3 ng/dL,CT示双侧肾上腺增大伴无实质强化及轻微周边包膜强化。

临床怎么用

  • 抗磷脂抗体阳性的COVID-19患者应密切监测急性肾上腺功能不全的症状或体征。

局限性

  • 本文为单例病例报告,文献回顾样本量小,部分病例激素数据不全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Coronavirus disease 2019 (COVID-19) is a proinflammatory and prothrombotic condition, but its impact on adrenal function has not been adequately evaluated. CASE REPORT: A 46-year-old woman presented with abdominal pain, hypotension, skin hyperpigmentation after COVID-19 infection. The patient had hyponatremia, serum cortisol <1.0 ug/dL, ACTH of 807 pg/mL and aldosterone <3 ng/dL. Computed tomography (CT) findings of adrenal enlargement with no parenchymal and minimal peripheral capsular enhancement after contrast were consistent with bilateral adrenal infarction. The patient had autoimmune hepatitis and positive antiphospholipid antibodies, but no previous thrombotic events. The patient was treated with intravenous hydrocortisone, followed by oral hydrocortisone and fludrocortisone. DISCUSSION: Among 115 articles, we identified nine articles, including case reports, of new-onset adrenal insufficiency and/or adrenal hemorrhage/infarction on CT in COVID-19. Adrenal insufficiency was hormonally diagnosed in five cases, but ACTH levels were measured in only three cases (high in one case and normal/low in other two cases). Bilateral adrenal non- or hemorrhagic infarction was identified in five reports (two had adrenal insufficiency, two had normal cortisol levels and one case had no data). Interestingly, the only case with well-characterized new-onset acute primary adrenal insufficiency after COVID-19 had a previous diagnosis of antiphospholipid syndrome. In our case, antiphospholipid syndrome diagnosis was established only after the adrenal infarction triggered by COVID-19. CONCLUSIONS: Our findings support the association between bilateral adrenal infarction and antiphospholipid syndrome triggered by COVID-19. Therefore, patients with positive antiphospholipid antibodies should be closely monitored for symptoms or signs of acute adrenal insufficiency during COVID-19.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Machado IFR, Menezes IQ, Figueiredo SR, et al. Primary adrenal insufficiency due to bilateral adrenal infarction in COVID-19: a case report. J Clin Endocrinol Metab. 2021. PMID: 34324679. doi:10.1210/clinem/dgab557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。